A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 247.74
GOOG 1.110.71
MSFT 149.70
FB 156.79
BAC 21.60

Recently Added

SEDG 82.37
CLOU 14.69
CLVS 7.13
CODX 9.15
RLLCF 0.00

Gaining Speed

SEDG 82.37
CLVS 7.13
CODX 9.15
CLOU 14.69
ADXS 0.56

Advaxis (ADXS) Reports Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC

Advaxis, Inc. (NASDAQ: ADXS) today announced results from the monotherapy and combination arms of the Company’s ongoing Phase 1/2 study investigating ADXS-503 in patients with non-small cell lung cancer (NSCLC) at the IASLC 2020 Targeted Therapies of Lung Cancer Meeting in Santa Monica, California. The trial is evaluating ADXS-503, part of the...

Read More




Get Alerted When News Hits On This Stock - FREE!